We focus on growth stage investments with a check size between $250k-$1M at a <$100M valuation, targeting a 2-3x return profile within a 5 year exit timeframe.
This syndicate is focused on a small number of high conviction deals instead of a large number of lower conviction deals. This approach allows us to spend meaningful time with the portfolio founders/CEOs around product strategy, commercialization, and other needs as their companies grow.
In addition to typical venture deals, we syndicate allocations in special situations (eg. secondary shares @ discount) and near-term exits (eg. pre-IPO shares) as they are available. For longer term investments, we look for strong teams, sticky products, and competitive moats with deal structures that address downside risk and allow for double-down opportunities.
We source deals through our network of founders, venture funds, family offices, with broad market visibility and deal flow across healthcare, fintech, and consumer. We syndicate all deals unless founder requests not to allow syndicate participation.